Preoperative CA-125, CA 19-9 and nuclear magnetic resonance in endometrial carcinoma: Correlation with surgical stage

Tumor Biology

Volumn 20, Issue 1, 1999, Pages 25-29

  Schneider, J ^a   Centeno, M ^a   Saez F ^a   Genolla J ^a   Ruibal, A ^b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Centro de Patologia de la Mama   (Spain)

Author keywords

Endometrial carcinoma; Nuclear magnetic resonance; Tumor markers

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; TUMOR MARKER;

ACCURACY; ARTICLE; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HYSTERECTOMY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY;

EID: 0032914934     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056518     Document Type: Article

References (11)

1. Announcements, FIGO stages -1988 Revision. Gynecol Oncol 1989;35:125-127.
2. Currie JL: Malignant tumors of the uterine corpus: in Thompson JD, Rock JA (eds): Te Linde's Operative Gynecology. Philadelphia, Lippincott, 1992.
3. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB: Surgical pathological spread patterns of endometrial cancer. Cancer 1987;60:2035-2041.
4. Belinson JL, Lee KR, Badger GJ, Pretorius MD, Jarrell MA: Clinical stage I adenocarcinoma of the endometrium: Analysis of recurrences and the potential benefit of staging lymphadenectomy. Gynecol Oncol 1992;44:17-23.
5. Larson DM, Johnson KK: Pelvic and para-aortic lymphadenectomy for surgical staging of high-risk endometrioid carcinoma of the endometrium. Gynecol Oncol 1993;51: 345-348.
6. Chen SS, Rumancik WM, Spiegel G: Magnetic resonance imaging in stage I endometrial carcinoma. Obstet Gynecol 1990;75:274-277.
7. Duk JM, Aalders JG, Fleuren GJ, de Bruijin AWA: CA-125: A useful marker in endometrial cancer. Am J Obstet Gynecol 1986;155:1097-1102.
8. Kukura V, Zaninovich I, Hrdina B: Concentrations of CA-125 tumor marker in endometrial carcinoma. Gynecol Oncol 1990;37:388-389.
9. Neunteufel W, Breitenecker G: CA 19-9, CA 125 and CEA in the endometrial mucosa during the menstrual cycle, in atypical hyperplasia and endometrial carcinoma. Cancer Lett 1989;48:77-83.
10. De Mulenaere GFGO: The case against Wertheim's hysterectomy in endometrial carcinoma. J Obstet Gynaecol Br Commonw 1973;80: 728-834.
11. Boronow RC, Morrow CP, Creasman WT, Di Saia PJ, Silverberg SG, Miller A, Blessing JA: Surgical staging in endometrial cancer: Clinical-pathologic findings of a prospective study. Obstet Gynecol 1984;63: 825-832.